Home
    Registration
    Accommodation
    Keep Me Updated
    Contact
  Home
  Welcome Note
  Committees
  List of Confirmed Faculty
  Timetable
  Scientific Program
  Poster Presentation Schedule
     Group A
     Group B
     Poster Presentation Guidelines
     E-Poster Upload
     Information About E-Posters
  Sponsorship & Exhibition
  Sponsors
  CME
  Registration
      Registration for Czech and Slovak Participants
     Macula Club Meeting
  Accompanying Persons Program
  Accommodation
     Clarion Congress Hotel
  About Prague
  General Information
     Transportation
     Tips & Hints
     Before you travel...
  Invitation Letter
  Links
  Contact Us
1st World Congress on
Controversies in Ophthalmology (COPHy)
Clarion Congress Hotel, Prague, Czech Republic March 4-7, 2010
 
  Scientific Program Print
 
Friday, March 5, 2010
   
Hall A
 
    
   
Session 1
SURGICAL RETINA I: MACULAR SURGERY
08:30-10:00
    
Chairperson: J. Moisseiev, Israel
Moderators: A. Augustin, Germany
Capsule:
Debates in macular surgery
    
08:30-09:15
08:30-08:45
08:45-09:00
09:00-09:15 
Debate: TO PEEL OR NOT TO PEEL THE INTERNAL LIMITING MEMBRANE (ILM)
Yes, ILM peeling is safe and improves surgical results:
J. Nawrocki, Poland
No, ILM peeling causes retinal damage and reduced visual outcomes:
W. Mieler, USA
Discussion
    
09:15-10:00
 
 
 
09:15-09:30
     
09:30-10:00
Panel Discussion: THE SURGICAL MANAGEMENT OF VARIOUS MACULAR PATHOLOGIES
Moderator: J. Moisseiev, Israel
Panel: A. Augustin, Germany; W. Mieler, USA; J. Nawrocki, Poland
  
P. Dugel, USA
(2) Panel discussion:
   
(a) Serous macular detachment from an optic pit
(b) Full thickness and lamellar macular holes, epiretinal membranes (ERMS), vitreomacular traction (VMT) syndrome
(c) Persistent subretinal fluid after buckling for retinal detachment (RD)
   
    
10:00-10:30
Coffee Break
      
10:30-12:00
RETINA SYMPOSIUM: NEW TREATMENT PARADIGMS IN RETINAL DISEASE
Sponsored by Allergan
Chairpersons: G. Coscas, France & A. Lowenstein, Israel
     
10:30-10:33
  
Introduction & Welcome
Chairpersons
     
10:33-10:45
  
  
10:45-10:57
 
 
10:57-11:09
 
 
11:09-11:21
  
  
11:21-11:33
  
  
11:33-11:45
Diagnosis in retinal disease: What are the different horizons?
W. Drexler, Austria
     
Inflammatory markers in retinal disease
J. Ambati, USA
  
Steroid differentiation in retinal disease
B. Kupperman, USA
  
A. Lowenstein, Israel
  
OZURDEX® in uveitis
S. Lightman, USA
  
Combination treatment in age-related macular disease (AMD)
A. Augustin, Germany
     
11:45-12:00
 
 
 
 
Panel Discussion: MANAGEMENT OF RETINAL DISEASE
Moderators: G. Coscas, France & A. Lowenstein, Israel
Panel: J. Ambati, USA; A. Augustin, Germany; W. Drexler, Austria; B. Kupperman, USA;
S. Lightman, USA
     
   
12:30-13:30
Lunch Break
     
Session 2
MEDICAL RETINA I: IS THERE REALLY AN IMPACT OF CATARACT SURGERY ON RETINAL DISEASE?
13:30-15:30
     
Chairperson: A. Augustin, Germany
Moderator: A. Pollack, Israel
Capsule:
Is there still a question as to whether cataract surgery can impact retinal disease?
    
13:30-14:15
13:30-13:45
13:45-14:00
14:00-14:15
Debate: THE EFFECT OF CATARACT ON DIABETIC RETINOPATHY
Diabetic retinopathy is affected by cataract surgery:
A. Pollack, Israel
Cataract surgery has very little effect on diabetic retinopathy:
A. Loewenstein, Israel
Discussion
    
14:15-15:00
14:15-14:30
14:30-14:45
14:45-15:00
Debate: THE EFFECT OF CATARACT ON MACULAR DEGENERATION
Macular degeneration is affected by cataract surgery:
A. Pollack, Israel
Cataract surgery has very little effect on macular degeneration:
S. Bressler, USA
Discussion
     
15:00-15:30
Panel Discussion: CONTROVERSIAL CASES WITH RETINA AND CATARACT
Moderator: B. Kupperman, USA  
Panel: A. Augustin, Germany; S. Bressler, USA; P. Dugel, USA; A. Loewenstein, Israel;
A. Pollack, Israel
  
(1) How should post-surgical cystoid macular edema be treated? First line therapy: What if topical nonsteroidal and topical steroidal drops are not working?
(2) Lattice degeneration prior to cataract surgery: Should prophylactic laser be used?
(3) Diabetic retinopathy and cataract: Combined surgery vs. cataract performed separately
   
     
15:30-16:00
Coffee Break
     
Session 3
SURGICAL RETINA II: CHANGING TRENDS IN VITREORETINAL SURGERY
16:00-18:00
    
Chairperson: J. Moisseiev, Israel
Moderators: A. Augustin, Germany
Capsule:
Retinal surgery techniques are continuously evolving
      
16:00-16:45
16:00-16:15
16:15-16:30
16:30-16:45
Debate: SHOULD WE BUCKLE OR PERFORM VITRECTOMY?
Yes, buckling is the procedure of choice:
J. Nawrocki, Poland
No, primary vitrectomy is the procedure of choice: W. Mieler, USA
Discussion
    
16:45-17:30
16:45-17:00
17:00-17:15
17:15-17:30
Debate: SURGERY FOR DIABETIC MACULOPATHY
Vitrectomy for diabetic maculopathy: W. Mieler, USA
Discussion
   
17:30-18:00
Panel Discussion: CONTROVERSIAL CASES IN RETINAL DETACHMENT
Moderator: Z. Gregor, UK
Panel: A. Augustin, Germany; P. Dugel, USA; F. Kuhn, USA; J. Moisseiev, Israel; W. Mieler, USA; J. Nawrocki, Poland
  
(1) What is the role of relaxing retinotomies in severe proliferative vitreoretinopathy (PVR)?
(2) How should retinal detachment from colobomas (including optic pits) be managed?
   
    
Hall B
       
Session 4
GLAUCOMA I: MANAGEMENT OF GLAUCOMA
08:30-10:00
  
Chairpersons: H.D. Jampel, USA & A. Heijl, Sweden
Capsule:
When to treat and how to test?
  
08:30-09:00
08:30-08:40
08:40-08:50
08:50-09:00
Debate: WHEN TO TREAT OCULAR HYPERTENSION?
Patients with a sufficiently high risk factor should have their intraocular presure (IOP) lowered:
F. Topouzis, Greece
Patients should have their IOP lowered only after demonstrating structural or functional damage:
A. Tuulonen, Finland
Discussion
  
09:00-09:30
09:00-09:10
09:10-09:20
09:20-09:30
Debate: TARGET PRESSURE: ESSENTIAL TOOL OR "COOKIE-CUTTER" MEDICINE?
All patients should have a target pressure towards which therapy is directed: H.D. Jampel, USA
Establishing a target pressure distracts from our therapeutic goals: A. Heijl, Sweden
Discussion
    
09:30-10:00
09:30-09:40
09:40-09:50
09:50-10:00
  
CONTROVERSIAL CASES REGARDING VARIOUS TOPICS IN GLAUCOMA
Prostaglandin analogues in the setting of macular edema: L. Rossetti, Italy
Panel discussion including all speakers
  
    
10:00-10:30
Coffee Break
   
      
Session 5
NEURO-OPHTHALMOLOGY I: PSEUDOTUMOR CEREBRI AND OTHER PATHOLOGIES
10:30-12:30
      
Chairpersons: A. Safran, Switzerland & A.G. Lee, USA
Capsule:
Pseudotumor cerebri remains a diagnostic and treatment challenge
       
10:30-11:30
10:30-10:50
10:50-11:10
11:10-11:30
Debate: WHAT IS THE BEST MANAGEMENT FOR PSEUDOTUMOR CEREBRI?
Medical:
P. Savino, USA
Surgical: N.R. Miller, USA
Discussion
  
11:30-12:30
 
 
 
 
 
 
 
Panel Discussion: CONTROVERSIAL CASES REGARDING IDIOPATHIC INTRACRANIAL HYPERTENSION AND OTHER
Moderator: A. Kesler, Israel
Panel: A.G. Lee, USA; N.R. Miller, USA; A. Safran, Switzerland; P. Savino, USA
   
(1) Magnetic resonance vengraphy (MRV) or CT venography for presumed idiopathic intracranial hypertension?
(2) Should stenting be offered to patients with presumed idiopathic intracranial hypertension and venous sinus thrombosis?
(3) Does radiation therapy improve thyroid eye disease?
(4) Does a patient with Horner Syndrome require pharmacologic testing to localize the lesion?
    
  
12:30-13:30
Lunch Break
     
Session 6
CATARACT I: CATARACT SURGERY
13:30-15:30
     
Chairpersons: E. Assia, Israel & W.J. Stark, USA
Capsule:
Albeit cataract being the most common surgical procedure in ophthalmology, there are still open questions
   
13:30-14:30
13:30-13:40
13:40-13:50
13:50-14:00
14:00-14:15
14:15-14:30
Debate: PRESBYOPIA CORRECTION IOLs
Multifocal IOLs: M. Pioviella, Italy
Accommodating IOLs:
B. Malyugin, Russia
Monovision: D. Sachs, Israel
Discussion
  
14:30-15:00
14:30-14:40
14:40-14:50
14:50-15:00
Debate: CLEAR LENS EXTRACTION: IS IT ETHICAL?
Probably not: J. Alio, Spain
Yes it is: S. Arshinoff, Canada
Discussion
    
15:00-15:30
 
 
15:00-15:07
15:07-15:15
15:15-15:23
  
15:23-15:30
VARIOUS TOPICS REGARDING MICRO-INCISION CATARACT SURGERY (MICS)
Moderator: S. Arshinoff, Canada
  
1.8mm coaxial technique: B. Malyugin, Russia
Bimanual technique:
J. Alio, Spain
Tri-MICS technique:
E. Assia, Israel 
  
(1) MICS: Technique and lenses
(2) Technique and instruments, clear corneal incision: Temporal, superior, oblique?
   
    
15:30-16:00
Coffee Break
      
Session 7
CATARACT II: CATARACT IN SPECIAL SITUATIONS
16:00-18:00
    
Chairpersons: J. Alio, Spain & B. Malyugin, Russia
Capsule: 
Despite increasing experience the best intraocular lenses (IOLs) for cataracts remains controversial
    
16:00-16:45
16:00-16:10
16:10-16:20
16:20-16:30
16:30-16:45
Debate: SMALL PUPIL: SURGICAL OPTIONS
Stretch and ophthalmic viscosurgical devices (OVDs) work best: D. Sachs, Israel
Iris hooks:
M. Piovella, Italy 
Papillary rings: B. Malyugin, Russia
Discussion
   
16:45-17:30
16:45-17:00
17:00-17:15
 
17:15-17:30
Debate: ASTIGMATIC CORRECTION DURING CATARACT SURGERY?
Yes, Cataract surgery is in any event a refractive surgery:
W.J. Stark, USA
Not a must, astigmatic keratotomy (AK)/limbal relaxing incision (LRI) is not accurate and harbor increased risks, and bioptics and toric IOLs are expensive: M. Piovella, Italy
DIscussion
   
17:30-18:00
17:30-17:40
17:40-17:50
17:50-18:00
Debate: SIMULTANEOUS MANAGEMENT OF BILATERAL CATARACTS
Simultaneous surgery is OK: S. Arshinoff, Canada 
Only in general anesthesia: E. Assia, Israel
Discussion
   
    
Hall C
          
Session 8 RETINOBLASTOMA
08:30-10:00
Chairpersons: F. Munier, Switzerland & L. Zografos, Switzerland
Capsule:
Retinoblastoma: There are still debates regarding management
     
08:30-09:00
 
  
08:30-08:37
08:37-08:43
08:43-08:50
08:50-09:00
Debate: TREATMENT OF ADVANCED (GROUP D AND E) RETINOBLASTOMA 
Chairperson: L. Zografos, Switzerland
     
External beam irradiation: J. Pe'er, Israel
Enucleation: T. Kivela, Finland
Intra-arterial chemotherapy: F. Munier, Switzerland
Discussion
    
09:00-09:30
 
 
 
09:00-09:10
09:10-09:20
09:20-09:30
Debate: BRACHYTHERAPY FOR THE TREATMENT OF RETINOBLASTOMA
Chairperson: B. Damato, UK
  
125l applicators: T. Kivela, Finland
106Ru/106Rh applicators: F. Munier, Switzerland
Discussion
   
09:30-10:00
 
 
09:30-09:40
09:40-09:50
09:50-10:00
  
Debate: PROTON BEAM VS. EXTERNAL BEAM RADIOTHERAPY FOR RETINOBLASTOMA
Chairperson: F. Munier, Switzerland
     
Proton beam irradiation: L. Zografos, Switzerland
External beam radiotherapy: T. Kivela, Finland
Discussion 
  
      
10:00-10:30 Coffee Break
           
Session 9 CORNEA DISEASE II: KERATOPLASTY AND KERATOCONUS
10:30-12:30    
Chairpersosn: W.J. Stark, USA
Capsule: 
Many new techniques for keratoplasty have evolved!
        
10:30-11:30
 
10:30-10:50
10:60-11:10
11:10-11:30
  
11:30-11:50
 
 
11:50-12:30
     
Discussion
 
Lecture: WHAT IS THE BEST TREATMENT FOR PROGRESSIVE KERATOCONUS?
J. Alio, Spain
 
Discussion: J. Alio, Spain; W.J. Stark, USA
    
     
12:30-13:30 Lunch Break
    
Session 10 OCULOPLASTICS I: LACRIMAL SYSTEM DISORDERS
13:30-15:30      
Chairpersons: G. Rose, UK & D. Paridaens, The Netherlands
Capsule: Oculoplastic surgery is a rapidly-developing field, but many issues in the medical and surgical management of patients are still controversial
  
13:30-13:55
 
13:30-13:37
13:37-13:45
13:45-13:55
Debate: ENDOSCOPIC OR EXTERNAL DACRYOCYSTORHINOSTOMY (DCR): WHICH IS PREFERABLE FOR NASO-LACRIMAL DUCT OBSTRUCTION IN ADULTS?
Endoscopic dacryocystorhinostomy (DCR): It is less invasive and the results are comparable:
N. Rosen, Israel
Discussion
   
13:55-14:20
13:55-14:03
14:03-14:10
14:10-14:20
Debate: MANAGEMENT OF CHILDHOOD EPIPHORA: PROBING, INTUBATION OR DCR?
Intubation is the treatment of choice for failed probings:
D. Paridaens, The Netherlands
Intubation has no proven role in failed probing: Reprobe, DCR or nothing:
G. Rose, UK
Discussion
   
14:20-14:45
14:20-14:27
14:27-14:35
14:35-14:45
Debate: MANAGEMENT OF UNILATERAL SEVERE CHILDHOOD PTOSIS
Unilateral surgery is best, as it avoids damage to the good side: J. Dickinson, UK
Bilateral procedures should always be performed, to achieve symmetry:
C. Hintschich, Germany
Discussion
   
14:45-15:30
Panel Discussion: CONTROVERSIES IN LIDS AND LACRIMAL
Moderator: D. Verity, UK
Panel: J. Dickinson, UK; C. Hintschich, Germany; D. Paridaens, The Netherlands;
G. Rose, UK; N. Rosen, Israel, U. Schaudig, Germany
  
(1) One-stitch vs. three-stitch ptosis correction
(2) Should congenital lacrimal fistulae have a DCR as well as fistula excision?
(3) Mohs tumor resection should be used for all tumors?
(4) How soon should DCR be performed after acute dacryocystitis?
(5) Should posterior approach ptosis repair be "retired" from service?
  
    
15:30-16:00 Coffee Break
    
Session 11
OCULOPLASTICS II: ORBITS AND SOCKET DISORDERS
16:00-18:00
     
Chairpersons: J. Dickinson, UK & C. Hintschich, Germany
Capsule:
Expert views in orbital diseases
      
16:00-16:25
16:00-16:07
16:07-16:15
16:15-16:25
Debate: DECOMPRESSION OR LID SURGERY TO CORRECT THYROID PROPTOSIS?
Decompression: It corrects more of the abnormalities:
D. Verity, UK
Eyelid surgery: It is simpler and has less complications:
G. Rose, UK
Discussion
   
16:25-16:50
16:25-16:33
16:33-16:40
16:40-16:50
Debate: EVISCERATION OR ENUCLEATION FOR BLIND EYES WITHOUT TUMOR?
Evisceration: The damage to orbital structures is less and rehabilitation is faster:
D. Paridaens, The Netherlands
Enucleation: A procedure without risk to the other eye:
C. Hintschich, Germany
Discussion
  
16:50-17:15
16:50-16:57
16:57-17:05
17:05-17:15
Debate: BIOPSY MUST BE PERFORMED BEFORE TREATING ALL INFILTRATIVE ORBITAL LESIONS
Biopsy all lesions, or diagnostic errors arise: U. Schaudig, Germany

Inflammation should be given a trial of steroids, as surgery can cause major exacerbation of orbital inflammation:
J. Dickinson, UK 
Discussion
    
17:15-18:00 Panel Discussion: CONTROVERSIES IN ORBITS AND SOCKETS
Moderator: U. Schaudig, Germany
Panel: J. Dickinson, UK; C. Hintschich, Germany; D. Paridaens, The Netherlands;
G. Rose, UK; N. Rosen, Israel; D. Verity, UK
   
(1) Is radiotherapy valuable in treatment of thyroid eye disease?
(2) Should possible pleomorphic adenomas be biopsied?
(3) Do porous implants play any role in sockets in this day and age?
(4) Is early repair of blowout fractures essential?
(5) Are dermis-fat grafts an unnecessarily complicated way of socket rehabilitation?

     

Saturday, March 6, 2010

Hall A
 
   
   
08:30-10:00
GLAUCOMA SYMPOSIUM: FUTURE GLAUCOMA MANAGEMENT
Sponsored by Allergan
Chairpersons: A. Heilj, Sweden & P. Denis, France
     
08:30-08:33
  
Introduction and Welcome
Chairpersons
   
08:33-08:48
 
 
08:48-09:03
 
 
09:03-09:18
 
 
09:18-09:33
 
 
09:33-09:45
Future diagnosis in glaucoma: New possibilities on the horizon
W. Drexler, Austria
 
How could we change our view on QoL and on priorities in glaucoma?
D. Crabb, UK
 
Current and future use of progression in clinical glaucoma management
A. Heijl, Sweden
 
Monotherapy in glaucoma 2010
P. Denis, France
 
How should we look at combination treatment in the future?
L. Rossetti, Italy
     
09:45-10:00
 
 
  
Panel Debate: What can we change now and what must wait for future development/research?
Moderator: A. Heijl, Sweden
Panel: D. Crabb, UK; P. Denis, France; W. Drexler, Austria; L. Rossetti, Italy
    
  
   
10:00-10:30
Coffee Break
 
    
10:30-12:30
DME SYMPOSIUM: OPTIMISING THERAPEUTIC BENEFITS OF RANIBIZUMAB IN PATIENTS WITH AMD
Sponsored by Novartis
Chairperson: N. Bressler, USA
      
10:30-10:40
  
Opening remarks
Chairperson
     
10:40-10:55
 
10:55-11:10
 
11:10-11:30
  
 
11:30-11:50
  
11:50-12:05
 
12:05-12:20
 
12:20-12:30
 
 
Safety in neovascular AMD: An in-depth review of ranibizumab
F. Bandello, Italy
Discussion
 
Evidence-based outcomes evaluation: Can the benefits seen in randomized clinical trials be transferred to the clinic?
N. Bressler, USA
Discussion
  
Predictors of treatment response: New sub analyses from clinical trials
U. Schmidt-Erfurth, Austria
Discussion
 
Summary
Chairperson
  
 
    
12:30-13:30
Lunch Break
 
       
Session 12
UVEITIS I: TREATMENT STRATEGIES FOR INTRAOCULAR INFLAMMATION
13:30-15:30
   
Chairperson: D.A. Jabs, USA
Capsule:
Intraocular inflammation has new treatment strategies
   
   
13:30-14:30
13:30-13:50
13:50-14:10
14:10-14:30
Debate: SCLERITIS: HOW SHOULD IT BE TREATED?
Regional steroids:
S. Lightman, UK
Systemic treatment:
J. Heissigerova, Czech Republic
Discussion
 
   
14:30-15:30
14:30-14:50
14:50-15:10
15:10-15:30
Discussion
   
 
    
15:30-16:00
Coffee Break
 
    
Session 13
UVEITIS II: TREATMENT OF INFLAMMATORY EYE DISEASE
16:00-18:00
   
Chairperson: S. Lightman, UK
Capsule:
Controversies still exist over the optimal management of inflammatory eye disease
 
   
16:00-16:45
16:00-16:15
16:15-16:30
16:30-16:45
Debate: BIOLOGICAL VS. CONVENTIONAL IMMUNOSUPPRESSION FOR UVEITIS
Conventional immunosuppression:
D.A. Jabs, USA 
Biological:
S. Lightman, UK
Discussion
 
  
16:45-17:30
Panel Discussion: CONTROVERSIAL CASES IN UVEITIS
Moderator: J. Forrester, UK
Panel: N. Archarya, USA; J. Heissigerova, Czech Republic; S. Lightman, UK
  
(1) What is the role of vitreoretinal surgery in uveitis?
(2) What is the best surgical approach for juvenile rheumatoid arthritis associated cataract?
(3) What is the role of intravitreal steroids in uveitis?
 
   
17:30-18:00
J. Forrester, UK
       
 
     
Hall B
 
  
    
Session 14
  
MEDICAL RETINA II: TREATMENT OF DIABETIC RETINOPATHY & DIABETIC MACULAR EDEMA (DME)
  
08:30-10:00
  
Chairperson: S. Bressler, USA
Moderators: F. Bandello, Italy & N. Bressler, USA
Capsule:
Treatments for diabetic macular edema address different pathogenic mechanisms: Do we know how best to utilize our options?
 
   
08:30-09:00
08:30-08:40
08:40-08:50
08:50-09:00
Debate: WHAT TREATMENT SHOULD BE USED IN CONJUNCTION WITH FOCAL/GRID LASER?
Corticosteroids:
B. Kupperman, USA
Anti-vascular endothelial growth factor (VEGF):
S. Bressler, USA
Discussion
 
   
09:00-09:30
09:00-09:10
09:10-09:20
09:20-09:30
Debate: USING OPTICAL COHERENCE TOMOGRAPHY (OCT) TO MANAGE DIABETIC MACULAR EDEMA
Spectral domain should be used whenever available:
U. Schmidt-Erfurth, Austria
Time domain is good enough:
M. Goldstein, Israel
Discussion
    
09:30-10:00 Panel Discussion: CONTROVERSIAL CASES IN PROLIFERATIVE DIABETIC RETINOPATHY (PDR)
Moderator: S. Bressler, USA
Panel: N. Bressler, USA; M. Goldstein, Israel; B. Kupperman, USA; Y. Yassur, Israel
   
(1) Pan-retinal photocoagulation (PRP) Techniques: Mild scatter or full scatter; Indirect or slit-lamp delivery; Automated mode delivery (e.g., Pascal laser) or manual delivery?
(2) If treating diabetic macular edema with an anti-VEGF drug in the setting of retinal neovascularization, do you also do PRP if there is PDR or wait until the anti-VEGF drug is discontinued?
(3) Advanced high-risk PDR: PRP initially, or PRP with anti-VEGF drugs or anti-VEGF drugs alone, or go right to vitrectomy?
  
 
   
10:00-10:30
Coffee Break
 
      
Session 15
NEURO-OPHTHALMOLOGY II: OPTIC NEUROPATHY
10:30-12:30
   
Chairperson: A.G. Lee, USA
Capsule:
Optic neuropathy has many faces and pauses many debates
 
   
10:30-11:15
10:30-10:45
10:45-11:00
11:00-11:15
Debate: WHAT IS THE BEST MANAGEMENT FOR NONARETERITIC OPTIC NEUROPATHY (NAION)?
Systemic steroids:
P. Savino, USA
Aspirin: A. Safran, Switzerland 
Avastin:
N.R. Miller, USA
Discussion
 
  
11:15-12:00
 
11:15-11:30
11:30-11:45
11:45-12:00
Debate: SHOULD A PATIENT WITH ACUTE OPTIC NEURITIS AND WHITE MATTER LESIONS BE TREATED FOR MULTIPLE SCLEROSIS AND HOW?
Yes:
A.G. Lee, USA
No:
P. Savino, USA
Discussion
 
  
12:00-12:30
Panel Discussion: CONTROVERSIAL CASES REGARDING SELECTED QUESTIONS IN NEUROOPHTHALMOLOGY
Moderator: P. Savino, USA 
Panel: A.G. Lee, USA; N.R. Miller, USA; A. Safran, Switzerland
  
(1) Should a patient with Giant cell arteritis have a unilateral or bilateral temporal artery biopsy?
(2) Does a patient with NAION need coagulation systemic evaluation?
(3) Do erectile dysfunction drugs cause an ischemic optic neuropathy?
(4) Does amiodarone cause an ischemic optic neuropathy?
(5) Should traumatic optic neuropathy be treated? If so: When and how?
  
 
    
12:30-13:30
Lunch Break
 
   
Session 16
   
MEDICAL RETINA III: NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (AND) AND GEOGRAPHIC ATROPHY
13:30-15:30
   
Chairperson: A. Augustin, Germany
Moderators: S. Bressler, USA & F. Bandello, Italy
Capsule:
Current treatment regimen for neovascular AMD
    
13:30-14:15
13:30-13:40
13:40-13:50
13:50-14:00
14:00-14:15
Debate: WHAT IS THE OPTIMAL TREATMENT OF NEOVASCULAR MACULAR DEGENERATION?
Ranibizumab monotherapy for all lesions monthly and at least 2 years:
N. Bressler, USA
PRN monotherapy:
A. Loewenstein, Israel 
Combination therapies:
A. Augustin, Germany
Discussion
    
14:15-15:00
 
14:15-14:30
14:30-14:45
14:45-15:00
Debate: IS THERE ADEQUATE EVIDENCE TO RECOMMEND BEVACIZUMAB OVER RANIBIZUAMB WHEN FINANCES ARE NOT AN ISSUE?
Yes:
U. Schmidt-Erfurth, Austria
No:
F. Bandello, Italy
Discussion
    
15:00-15:30
15:00-15:10
15:10-15:20
15:20-15:30
Debate: IS AUTOFLUORESCENCE NEEDED IN THE MANAGEMENT OF NEOVASCULAR AMD OR GEOGRAPHIC ATROPHY?
Yes
U. Schmidt-Erfurth, Austria
No:
S. Bressler, USA
Discussion
  
 
   
15:30-16:00
Coffee Break
 
   
Session 17
MEDICAL RETINA IV: MANAGEMENT OF MACULAR EDEMA IN VEIN OCCLUSION
16:00-18:00
   
Chairperson: B. Kupperman, USA
Moderator: A. Augustin, Germany
Capsule:
Treatment modalities of venous occlusive diseases
     
16:00-16:45
16:00-16:10
16:10-16:20
16:20-16:30
16:30-16:45
Debate: MANAGEMENT IN BRANCH VEIN OCCLUSION
Laser treatment:
D. Finkelstein, USA
Intravitreal corticosteroids: Alone or with laser:
B. Kupperman, USA
Intravitreal anti-VEGF: Alone or with laser:
F. Bandello, Italy
Discussion
     
16:45-17:30
16:45-17:00
17:00-17:15
17:15-17:30
Debate: MANAGEMENT IN CENTRAL VEIN OCCLUSION
Intravitreal corticosteroids:
A. Loewenstein, Israel
Intravitreal anti-VEGF:
S. Bressler, USA
Discussion
   
17:30-18:00
Panel Discussion: CONTROVERSIAL CASES OF CENTRAL VEIN OCCLUSION WITH NONPERFUSION
Moderator: D. Finkelstein, USA 
Panel: F. Bandello, Italy; B. Kupperman, USA
  
(1) Is a fluorescein angiogram needed?
(2) Should PRP be placed right away?
(3) If edema is being treated with anti-VEGF, and there is iris neovascularization, is PRP also indicated while providing anti-VEGF? When anti-VEGF is discontinued?
(4) Is a medical work-up indicated?
      
 
   
Hall C
 
   
    
Session 18
CATARACT III: CATARACTS IN COMPLICATED OCULAR SITUATIONS AND COMPLICATIONS OF SURGERY
08:30-10:00
   
Chairpersons: E. Assia, Israel; W.J. Stark, USA
Capsule:
A cataract surgeon still faces complex situations and a variety of complications
 
   
08:30-09:15
08:30-08:40
08:40-08:55
08:55-09:10
09:10-09:15
Debate: SUBLUXATED INTRAOCULAR LENSES
Discussion
    
09:15-10:00
09:15-09:25
09:25-09:35
09:35-09:45
  
09:45-10:00
 
Debate: PREOPERATIVE CARE
Best antibiotic is ceforoxime (the European experience): M. Piovella, Italy
Discussion
      
 
         
10:00-10:30
Coffee Break
 
   
Session 19
TUMORS I: UVEAL MELANOMA
10:30-12:30
   
Chairpersons: L. Zografos, Switzerland & E. Gragoudas, USA
Capsule:
Many controversies exist in the treatment of uveal melanoma
 
     
10:30-11:30
 
 
10:30-10:45
10:45-11:00
11:00-11:15
11:15-11:30
Debate: WHAT IS THE BEST CONSERVATIVE MANAGEMENT OF UVEAL MELANOMA?
Chairperson: L. Zografos, Switzerland
 
Plaque radiotherapy: J. Pe'er, Israel
Proton beam irradiation: E. Gragoudas, USA
Surgical resection:
B. Damato, UK
Discussion
 
   
11:30-12:00
 
 
11:30-11:40
11:40-11:50
11:50-12:00
Debate: MELANOMA: SHOULD WE PERFORM SYSTEMIC EVALUATION?
Chairperson: J. Pe'er, Israel
  
Yes: B. Damato, UK
No:
E. Gragoudas, USA
Discussion
 
   
12:00-12:30
 
  
 
12:00-12:10
12:10-12:20
12:20-12:30
Debate: IS IT RECOMMENDED TO PERFORM A FINE NEEDLE ASPIRATION BIOPSY IN UVEAL MELANOMAS BEFORE CONSERVATIVE TREATMENT?
Chairperson: E. Gragoudas, USA
  
Yes: B. Damato, UK
No: L. Zografos, Switzerland
Discussion
    
 
   
12:30-13:30
Lunch Break
 
    
Session 20
PEDIATRIC OPHTHALMOLOGY & STRABISMUS I: STRABISMUS SURGERY
13:30-15:30
     
Chairperson: TBA
Capsule:
What is the optimal surgical treatment of various strabismus conditions?
 
    
13:30-14:15
13:30-13:45
13:45-14:00
14:00-14:15
Debate: NYSTAGMUS SURGERY
Conservative approach is warranted:
TBA
Radical thinking is the best:
R. Hertle, USA
Discussion
 
   
14:15-15:00
14:15-14:30
14:30-14:45
14:45-15:00
Debate: STRABISMUS SURGERY
Minimally invasive:
D. Mojon, Switzerland
Invasive:
D. Mojon, Switzerland
Discussion
 
    
15:00-15:30
15:00-15:10
15:10-15:20
15:20-15:30
Debate: THYROID RELATED STRABISMUS
Early surgery is preferable:
D. Granet, USA
We should postpone surgery as much as possible:
D. Mojon, Switzerland
Discussion
    
  
   
15:30-16:00
Coffee Break
   
       
Session 21
TRAUMA I: OPEN GLOBE INJURY
16:00-18:00
     
Chairpersons: F. Kuhn, USA & J. Moisseiev, Israel
Capsule:
Management of open globe injury remains one of the most controversial problems in ophthalmology
 
    
16:00-16:45
16:00-16:15
16:15-16:30
16:30-16:45
Debate: TIMING OF VITRECTOMY IN POSTERIOR SEGMENT TRAUMA
Early vitrectomy: F. Kuhn, USA
Delayed vitrectomy: W. Mieler, USA
Discussion
 
    
16:45-18:00
Panel Discussion: THE MANAGEMENT OF POSTERIOR SEGMENT INJURY: CASE PRESENTATION
Capsule: The panel will discuss the management of intraocular foreign bodies, open globe injury and blunt trauma. Cases and surgical videos will be presented to the panel, and the various dilemmas and treatment options will be thoroughly discussed
  
Moderators: J. Moisseiev, Israel & F. Kuhn, USA
Panel: A. Augustin, Germany; A. Barak, Israel; J. Nawrocki, Poland
    

     

Sunday, March 7, 2010

Hall A
      
Session 22 SOCIOECONOMIC AND ETHICAL CONSIDERATIONS: INDUSTRY CONSIDERATIONS
08:30-10:00    
Chairperson: N. Bressler, USA
Capsule:
 
Our management of patient disease depends not only on individual patient condition but also on general socioeconomic situations and upon ethical considerations
   
08:30-09:15
 
 
 
 
08:30-08:45
08:45-09:15
 
Panel discussion: PROS AND CONS REGARDING INDUSTRY INTERACTIONS WITH CONTINUING MEDICAL EDUCATION
Moderator: N. Bressler, USA
Panel: A. Loewenstein, Israel; Z. Gregor, UK, D.A. Jabs, USA
   
(1) Industry funding of continuing medical education
(2) Is participation in speakers bureaus unprofessional conduct for physicians who participate in continuing medical education?
     
09:15-09:30
D. Finkelstein, USA 
     
09:30-10:00
09:30-09:40
 
09:40-09:50
09:50-10:00
 
Debate: SCREENING OF PATIENTS FOR VARIOUS EYE DISEASE
Con: Screening causes vomit syndrome: A.R. Shapira, Israel
Discussion
  
      
10:00-10:30
Coffee Break
     
Session 23
   
REFRACTIVE SURGERY I: HOT CONTROVERSIES IN KERATOCONUS AND KERATOECTASIA & ASTIGMATISM CORRECTION
10:30-12:30      
Chairpersons: J. Murta, Portugal & J. Alio, Spain
Capsule:
Newest concepts in refractive surgery
       
10:30-11:15
  
  
Panel discussion: CONTROVERSIAL CASES REGARDING TREATMENT OF KERATECSASIA
Moderator: J. Colin, France
Panel: M. Holzer, Germany; G. Kymionis, Greece; J. Murta, Portugal
   
(1) When should a post-laser-assisted in situ keratomileusis (LASIK) keratoectatic eye be treated?
(2) Should the fellow eye be treated?
      
11:15-12:00
     
Panel discussion: CONTROVERSIAL CASES REGARDING TREATMENT OF MYOPIA
Moderator: J. Alio, Spain
Panel: M. Holzer, Germany; G. Kymionis, Greece
   
(1) What is the perfect management for myopia: Surface ablation or flap?
(2) What is the best way to perform flap? Mechanical microkeratome or Femtosecond laser?
   
12:00-12:30
Panel discussion: CONTROVERSIAL CASES REGARDING ASTIGMATISM CORRECTION
Moderator: J. Alio, Spain
Panel: W.J. Stark, USA; G. Kymionis, Greece; J. Murta, Portugal
 
(1) How should three diopters of astigmatism be treated?
(2) Relaxing incisions (blade or laser)
(3) Toric IOL
  
   
Hall B
     
Session 24
  
DIAGNOSIS AND THERAPY OF PEDIATRIC RETINAL DYSTROPHIES
Sponsored by EPOS
08:30-10:00    
 
Mutation screening of patients with inherited retinal dystrophies: Which method, against what costs, and who will pay?
F. Cremers, The Netherlands
  
B. Lorenz, Germany
   
The development of AAV vectors for retinal gene therapy: Advantages and limitations
E. Surace, Italy
   
Accessibility of retinal degenerations to gene therapy
K. Stieger, Germany
    
   
  
10:00-10:30 Coffee Break
    
Session 25 PEDIATRIC OPHTHALMOLOGY & STRABISIMUS II: PEDIATRIC OPHTHALMOLOGY
10:30-12:30      
Chairpersons: K.K. Nischal, UK
Capsule: Should all adult technologies be applied to children?
  
10:30-11:15
10:30-10:45
10:45-11:00
11:00-11:15
Debate: REFRACTIVE SURGERY IN CHILDREN
Yes: E. Paysse, USA
No:
D. Granet, USA
Discussion
   
11:15-12:00
11:15-11:45
11:45-12:00
Debate: AVASTIN IN RETINOPATHY OF PREMATURITY
State of the artH. Mintz-Hittner, USA
Questions to the expert: K.K. Nischal, UK
      
12:00-12:30
Panel Discussion: CONTROVERSIAL CASES REGARDING CATARACTS IN CHILDREN
Moderator: K.K. Nischal, UK
Panel: E. Paysse, USA: H. Stolovich, Israel
   
(1) Should an IOL be implanted?
(2) Should we perform posterior capsulorhexis?
   
   
Hall C
       
Session 26
TRAUMA II: TRAUMATIC CATARACT IN ADULTS AND CHILDREN
08:30-10:00
 
Chairpersons: F. Kuhn, USA; J. Moisseiev, Israel
Capsule: Traumatic eye injury is one of the most controversial problems and requires collaboration of most subfields in ophthalmology
   
08:30-09:00
08:30-08:40
08:40-08:50
08:50-09:00
Debate: TRAUMATIC CATARACT IN ADULTS AND CHILDREN
Primary lens removal and IOL implantation: E. Assia, Israel
Discussion
     
09:00-10:00
09:00-09:20
09:20-09:40
  
09:40-10:00
CONTROVERSIAL CAES IN TRAUMA MANAGEMENT
Orbital and eyelid trauma: N. Rosen, Israel
    
          
10:00-10:30 Coffee Break


Home   
Copyright © 2008 Comtecmed.com. All rights reserved. Created by    WebStudio.co.il